This observational analysis shows significant improvement in psychological symptoms in participants undergoing jungian psychotherapy, suggesting its potential value in treatment settings.
Jungian psychotherapy (JP) is an established treatment modality in modern healthcare systems, yet empirical validation remains a key requirement for its continued recognition and insurance coverage. This study aimed to assess the effectiveness of JP by evaluating pre- and post-treatment changes in psychological symptoms, personality structure, and quality of life among 104 participants undergoing supervised therapy at a German training institute. Using a pre-post design, participants completed standardized psychometric assessments, including the International Classification of Diseases – 10th Revision (ICD-10) Symptom Rating (ISR), the Fragebogen zur Lebenszufriedenheit (FLZ; Life Satisfaction Questionnaire), and the Operationalized Psychodynamic Diagnosis - Structure Questionnaire (OPD-SQ), before and after therapy. Results from paired samples t-tests and Wilcoxon signed-rank tests indicated significant improvements across multiple domains. Participants experienced notable reductions in symptom burden, particularly in depression, anxiety, and obsessive-compulsive symptoms, with effect sizes ranging from moderate to large (d=0.555 to d=1.174). Improvements were also observed in self-perception, interpersonal contact, and relational experiences. However, eating disorder symptoms did not show significant improvement (p=.275), likely due to the need for specialized interventions. Future research should employ randomized controlled trials (RCTs) and long-term follow-ups to establish the durability of treatment effects.
No takes yet. Share an insight, caveat, or question.
Rœsler et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: